Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 43 | 2024 | 1128 | 6.690 |
Why?
|
| Mammography | 26 | 2024 | 273 | 5.190 |
Why?
|
| Breast Diseases | 12 | 2023 | 39 | 3.360 |
Why?
|
| Contrast Media | 8 | 2023 | 414 | 2.400 |
Why?
|
| Breast | 10 | 2023 | 173 | 2.200 |
Why?
|
| Magnetic Resonance Imaging | 21 | 2023 | 2049 | 1.760 |
Why?
|
| Societies, Medical | 11 | 2024 | 331 | 1.390 |
Why?
|
| Image-Guided Biopsy | 5 | 2018 | 37 | 1.390 |
Why?
|
| Early Detection of Cancer | 12 | 2024 | 267 | 1.070 |
Why?
|
| Female | 64 | 2024 | 31095 | 1.010 |
Why?
|
| Precancerous Conditions | 3 | 2021 | 72 | 0.980 |
Why?
|
| Diagnostic Imaging | 5 | 2023 | 242 | 0.970 |
Why?
|
| Homosexuality, Female | 1 | 2023 | 21 | 0.860 |
Why?
|
| Radiographic Image Enhancement | 2 | 2020 | 98 | 0.850 |
Why?
|
| Radiology | 5 | 2021 | 233 | 0.820 |
Why?
|
| Humans | 73 | 2024 | 59810 | 0.800 |
Why?
|
| Breast Carcinoma In Situ | 1 | 2021 | 3 | 0.770 |
Why?
|
| Sexual and Gender Minorities | 1 | 2023 | 73 | 0.770 |
Why?
|
| Ultrasonography, Mammary | 6 | 2019 | 16 | 0.770 |
Why?
|
| Carcinoma, Lobular | 1 | 2021 | 23 | 0.760 |
Why?
|
| Carcinoma in Situ | 1 | 2021 | 33 | 0.750 |
Why?
|
| Parenchymal Tissue | 1 | 2020 | 4 | 0.730 |
Why?
|
| Practice Management, Medical | 2 | 2018 | 20 | 0.720 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 332 | 0.680 |
Why?
|
| Health Services Accessibility | 2 | 2024 | 543 | 0.670 |
Why?
|
| Biopsy | 4 | 2017 | 375 | 0.650 |
Why?
|
| Cerebral Ventricles | 6 | 2011 | 29 | 0.650 |
Why?
|
| Middle Aged | 26 | 2023 | 16400 | 0.640 |
Why?
|
| Video Recording | 2 | 2017 | 126 | 0.640 |
Why?
|
| Mass Screening | 7 | 2024 | 658 | 0.600 |
Why?
|
| Retrospective Studies | 18 | 2023 | 6041 | 0.590 |
Why?
|
| Lymph Nodes | 2 | 2018 | 212 | 0.590 |
Why?
|
| Workflow | 1 | 2018 | 63 | 0.580 |
Why?
|
| Incidental Findings | 1 | 2017 | 41 | 0.570 |
Why?
|
| Sensitivity and Specificity | 10 | 2023 | 1098 | 0.540 |
Why?
|
| Education, Medical, Graduate | 4 | 2023 | 313 | 0.530 |
Why?
|
| Teaching Materials | 1 | 2016 | 10 | 0.530 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2018 | 63 | 0.530 |
Why?
|
| Ultrasonography, Prenatal | 9 | 2011 | 43 | 0.520 |
Why?
|
| Radiology, Interventional | 1 | 2016 | 29 | 0.510 |
Why?
|
| Adult | 24 | 2023 | 15882 | 0.510 |
Why?
|
| Stereotaxic Techniques | 2 | 2014 | 29 | 0.510 |
Why?
|
| Aged | 16 | 2020 | 13461 | 0.500 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 107 | 0.480 |
Why?
|
| Fetal Diseases | 4 | 2011 | 21 | 0.470 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 278 | 0.470 |
Why?
|
| Evidence-Based Medicine | 8 | 2024 | 454 | 0.460 |
Why?
|
| Continuity of Patient Care | 1 | 2015 | 173 | 0.450 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 272 | 0.440 |
Why?
|
| Diagnosis, Differential | 8 | 2019 | 906 | 0.430 |
Why?
|
| Liver | 1 | 2017 | 788 | 0.420 |
Why?
|
| Biopsy, Large-Core Needle | 4 | 2021 | 18 | 0.420 |
Why?
|
| Prenatal Diagnosis | 4 | 2011 | 39 | 0.420 |
Why?
|
| Patient Care Team | 1 | 2015 | 333 | 0.410 |
Why?
|
| Aged, 80 and over | 10 | 2020 | 5149 | 0.410 |
Why?
|
| Needles | 2 | 2018 | 64 | 0.410 |
Why?
|
| Epithelial Cells | 1 | 2014 | 376 | 0.390 |
Why?
|
| Gynecomastia | 2 | 2018 | 11 | 0.390 |
Why?
|
| Quality of Health Care | 2 | 2015 | 524 | 0.390 |
Why?
|
| Breast Implants | 2 | 2023 | 13 | 0.370 |
Why?
|
| Fellowships and Scholarships | 3 | 2023 | 99 | 0.360 |
Why?
|
| Calcinosis | 3 | 2019 | 79 | 0.320 |
Why?
|
| Breast Density | 4 | 2022 | 16 | 0.310 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2019 | 26 | 0.300 |
Why?
|
| Radiologists | 2 | 2019 | 75 | 0.300 |
Why?
|
| United States | 14 | 2024 | 7570 | 0.280 |
Why?
|
| Cultural Competency | 2 | 2024 | 50 | 0.270 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2019 | 167 | 0.260 |
Why?
|
| Pregnancy, Ectopic | 2 | 2008 | 12 | 0.250 |
Why?
|
| Central Nervous System | 2 | 2005 | 192 | 0.240 |
Why?
|
| Decidua | 1 | 2004 | 3 | 0.240 |
Why?
|
| Translating | 1 | 2024 | 17 | 0.230 |
Why?
|
| Hyperplasia | 2 | 2021 | 85 | 0.220 |
Why?
|
| Communication Barriers | 1 | 2024 | 59 | 0.220 |
Why?
|
| Culture | 1 | 2024 | 76 | 0.220 |
Why?
|
| Ultrasonography, Doppler | 1 | 2003 | 24 | 0.220 |
Why?
|
| Pregnancy | 12 | 2018 | 2359 | 0.210 |
Why?
|
| Gender Identity | 1 | 2023 | 61 | 0.210 |
Why?
|
| Image Enhancement | 2 | 2015 | 190 | 0.210 |
Why?
|
| Patient Navigation | 1 | 2023 | 35 | 0.210 |
Why?
|
| Transaminases | 1 | 2022 | 11 | 0.200 |
Why?
|
| Clinical Competence | 4 | 2018 | 685 | 0.200 |
Why?
|
| Sexual Behavior | 1 | 2023 | 183 | 0.200 |
Why?
|
| Research | 1 | 2023 | 190 | 0.200 |
Why?
|
| Time Factors | 3 | 2019 | 3590 | 0.190 |
Why?
|
| Reproducibility of Results | 6 | 2016 | 1559 | 0.190 |
Why?
|
| Observer Variation | 2 | 2020 | 201 | 0.190 |
Why?
|
| Needs Assessment | 1 | 2023 | 192 | 0.190 |
Why?
|
| Serine | 1 | 2022 | 83 | 0.190 |
Why?
|
| Educational Status | 1 | 2023 | 273 | 0.190 |
Why?
|
| Age Factors | 3 | 2020 | 1521 | 0.190 |
Why?
|
| Gestational Age | 6 | 2011 | 184 | 0.180 |
Why?
|
| Artificial Intelligence | 1 | 2023 | 172 | 0.180 |
Why?
|
| Transgender Persons | 1 | 2021 | 63 | 0.180 |
Why?
|
| Ischemia | 1 | 2002 | 193 | 0.180 |
Why?
|
| Predictive Value of Tests | 3 | 2022 | 1030 | 0.180 |
Why?
|
| Patient Preference | 2 | 2021 | 77 | 0.170 |
Why?
|
| Thrombectomy | 1 | 2002 | 207 | 0.170 |
Why?
|
| Mammaplasty | 1 | 2020 | 44 | 0.170 |
Why?
|
| Surveys and Questionnaires | 3 | 2023 | 2601 | 0.170 |
Why?
|
| Thrombosis | 1 | 2002 | 190 | 0.170 |
Why?
|
| Iohexol | 1 | 2019 | 18 | 0.160 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2019 | 47 | 0.160 |
Why?
|
| Neoadjuvant Therapy | 1 | 2019 | 71 | 0.160 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2023 | 302 | 0.160 |
Why?
|
| Mastodynia | 1 | 2018 | 3 | 0.160 |
Why?
|
| Forecasting | 1 | 2019 | 221 | 0.160 |
Why?
|
| Papilloma | 1 | 2018 | 12 | 0.160 |
Why?
|
| Menopause | 1 | 2020 | 247 | 0.150 |
Why?
|
| Lymphatic Metastasis | 1 | 2018 | 68 | 0.150 |
Why?
|
| Educational Measurement | 2 | 2017 | 210 | 0.150 |
Why?
|
| Job Satisfaction | 1 | 2018 | 134 | 0.150 |
Why?
|
| Efficiency, Organizational | 1 | 2018 | 95 | 0.140 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 315 | 0.140 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 67 | 0.140 |
Why?
|
| Burnout, Professional | 1 | 2018 | 123 | 0.130 |
Why?
|
| Carcinoma | 1 | 2017 | 117 | 0.130 |
Why?
|
| Ultrasonography | 3 | 2010 | 459 | 0.130 |
Why?
|
| Computers, Handheld | 1 | 2016 | 37 | 0.130 |
Why?
|
| Postoperative Complications | 2 | 2018 | 1142 | 0.130 |
Why?
|
| Male | 8 | 2023 | 27766 | 0.130 |
Why?
|
| Patient Safety | 1 | 2018 | 244 | 0.130 |
Why?
|
| Internship and Residency | 3 | 2017 | 736 | 0.130 |
Why?
|
| Mucocele | 1 | 2015 | 2 | 0.120 |
Why?
|
| Central Nervous System Diseases | 2 | 2008 | 56 | 0.120 |
Why?
|
| Patient Care | 1 | 2015 | 78 | 0.120 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2015 | 15 | 0.120 |
Why?
|
| Prospective Studies | 4 | 2016 | 3110 | 0.120 |
Why?
|
| Vacuum | 1 | 2014 | 8 | 0.120 |
Why?
|
| Attitude to Health | 1 | 2016 | 279 | 0.120 |
Why?
|
| Transsexualism | 1 | 2014 | 13 | 0.110 |
Why?
|
| Health Promotion | 1 | 2018 | 490 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 647 | 0.110 |
Why?
|
| Health Care Reform | 1 | 2015 | 88 | 0.110 |
Why?
|
| Culturally Competent Care | 2 | 2024 | 16 | 0.110 |
Why?
|
| Patient Positioning | 1 | 2014 | 42 | 0.110 |
Why?
|
| Curriculum | 4 | 2023 | 563 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 716 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 707 | 0.100 |
Why?
|
| Mammary Glands, Human | 1 | 2012 | 50 | 0.100 |
Why?
|
| Neoplasms | 1 | 2022 | 1258 | 0.100 |
Why?
|
| Pregnancy Outcome | 3 | 2011 | 189 | 0.100 |
Why?
|
| Fibroadenoma | 1 | 2011 | 3 | 0.100 |
Why?
|
| Prevalence | 2 | 2015 | 1288 | 0.090 |
Why?
|
| Septum Pellucidum | 1 | 2011 | 4 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 1470 | 0.090 |
Why?
|
| Echoencephalography | 1 | 2009 | 14 | 0.080 |
Why?
|
| Receptors, Estrogen | 2 | 2023 | 124 | 0.080 |
Why?
|
| Algorithms | 1 | 2015 | 998 | 0.080 |
Why?
|
| Intracranial Hemorrhages | 1 | 2009 | 62 | 0.080 |
Why?
|
| Adnexal Diseases | 1 | 2008 | 8 | 0.080 |
Why?
|
| Mastectomy | 2 | 2020 | 54 | 0.070 |
Why?
|
| Boston | 2 | 2020 | 333 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2024 | 1918 | 0.070 |
Why?
|
| Adolescent | 3 | 2011 | 5939 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 1 | 2005 | 301 | 0.060 |
Why?
|
| Silicones | 1 | 2023 | 12 | 0.060 |
Why?
|
| Breast Implantation | 1 | 2003 | 7 | 0.050 |
Why?
|
| Area Under Curve | 1 | 2023 | 125 | 0.050 |
Why?
|
| Thorax | 1 | 2003 | 33 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2003 | 74 | 0.050 |
Why?
|
| Physical Examination | 1 | 2023 | 103 | 0.050 |
Why?
|
| Organoids | 1 | 2023 | 40 | 0.050 |
Why?
|
| Fetus | 1 | 2003 | 97 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 143 | 0.050 |
Why?
|
| Rheology | 1 | 2002 | 67 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2011 | 577 | 0.050 |
Why?
|
| Documentation | 1 | 2023 | 129 | 0.050 |
Why?
|
| Leg | 1 | 2002 | 83 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2023 | 370 | 0.050 |
Why?
|
| Computer-Assisted Instruction | 1 | 2002 | 76 | 0.050 |
Why?
|
| Counseling | 1 | 2003 | 352 | 0.040 |
Why?
|
| Phantoms, Imaging | 1 | 2002 | 212 | 0.040 |
Why?
|
| Breast Neoplasms, Male | 1 | 2018 | 14 | 0.040 |
Why?
|
| Decision Support Techniques | 1 | 2020 | 180 | 0.040 |
Why?
|
| Communication | 1 | 2023 | 556 | 0.040 |
Why?
|
| Infant | 1 | 2023 | 1527 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2019 | 98 | 0.040 |
Why?
|
| Lactation | 1 | 2018 | 71 | 0.040 |
Why?
|
| Physicians, Primary Care | 1 | 2019 | 72 | 0.040 |
Why?
|
| Organizational Culture | 1 | 2018 | 112 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 4363 | 0.030 |
Why?
|
| Leadership | 1 | 2018 | 201 | 0.030 |
Why?
|
| Benchmarking | 1 | 2017 | 135 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2022 | 659 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 927 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 743 | 0.030 |
Why?
|
| Organizational Objectives | 1 | 2015 | 58 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2015 | 92 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2015 | 147 | 0.030 |
Why?
|
| Massachusetts | 1 | 2019 | 2112 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2002 | 5205 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 207 | 0.020 |
Why?
|
| Radiography | 1 | 2011 | 513 | 0.020 |
Why?
|
| Technology, Radiologic | 1 | 2008 | 9 | 0.020 |
Why?
|
| Professional Practice | 1 | 2008 | 22 | 0.020 |
Why?
|
| Genital Neoplasms, Female | 1 | 2008 | 19 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2008 | 97 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 1252 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 5038 | 0.010 |
Why?
|
| Reference Standards | 1 | 2002 | 61 | 0.010 |
Why?
|
| Endosonography | 1 | 2002 | 33 | 0.010 |
Why?
|
| Abdomen | 1 | 2002 | 90 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 402 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2002 | 228 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2002 | 131 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2002 | 458 | 0.010 |
Why?
|